We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+12.65%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.75B
AUM Growth
+$182M
Cap. Flow
+$1.02M
Cap. Flow %
0.06%
Top 10 Hldgs %
16.22%
Holding
890
New
91
Increased
326
Reduced
388
Closed
74

Sector Composition

Rank Sector Weight
1 Healthcare 12.42%
2 Financials 10.3%
3 Technology 8.72%
4 Industrials 4.92%
5 Consumer Discretionary 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
501
Wells Fargo
WFC
$264B
$666K 0.04%
13,533
-1,094
-7% -$47.2K
AOS icon
502
A.O. Smith
AOS
$8.65B
$663K 0.04%
8,039
-745
-8% -$54.9K
APTV icon
503
Aptiv
APTV
$10.3B
$659K 0.04%
7,343
-340
-4% -$29.3K
BGX
504
Blackstone Long-Short Credit Income Fund
BGX
$138M
$653K 0.04%
57,065
-21,158
-27% -$241K
SNY icon
505
Sanofi
SNY
$104B
$651K 0.04%
13,095
+2,767
+27% +$135K
NDAQ icon
506
Nasdaq
NDAQ
$53.1B
$647K 0.04%
11,121
-171
-2% -$9.02K
RNAM
507
DELISTED
Avidity Biosciences
RNAM
$644K 0.04%
71,195
+4,975
+8% +$33.3K
ROCK icon
508
Gibraltar Industries
ROCK
$1.48B
$639K 0.04%
8,091
+2,134
+36% +$146K
SKM icon
509
SK Telecom
SKM
$12.9B
$637K 0.04%
29,754
+12,342
+71% +$261K
EXR icon
510
Extra Space Storage
EXR
$31B
$637K 0.04%
3,971
-2,911
-42% -$370K
AUPH icon
511
Aurinia Pharmaceuticals
AUPH
$2.04B
$636K 0.04%
70,744
+8,658
+14% +$71.3K
JPI
512
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
$633K 0.04%
34,634
-265
-0.8% -$4.57K
IVZ icon
513
Invesco
IVZ
$13.8B
$633K 0.04%
35,484
+24,277
+217% +$350K
UTHR icon
514
United Therapeutics
UTHR
$22.1B
$633K 0.04%
2,878
-41
-1% -$9.45K
CMS icon
515
CMS Energy
CMS
$21.8B
$628K 0.04%
10,822
-109
-1% -$6.09K
GPN icon
516
Global Payments
GPN
$22.7B
$625K 0.04%
4,920
+65
+1% +$7.53K
PTC icon
517
PTC
PTC
$16.3B
$623K 0.04%
3,562
-2,543
-42% -$390K
LRCX icon
518
Lam Research
LRCX
$390B
$614K 0.04%
7,840
+3,810
+95% +$260K
LOPE icon
519
Grand Canyon Education
LOPE
$3.76B
$611K 0.03%
4,624
+1,219
+36% +$159K
ETX
520
Eaton Vance Municipal Income 2028 Term Trust
ETX
$199M
$604K 0.03%
34,826
-349
-1% -$5.97K
HUBG icon
521
HUB Group
HUBG
$2.32B
$600K 0.03%
13,048
-1,536
-11% -$60.3K
THR
522
DELISTED
Thermon Group Holdings
THR
$600K 0.03%
18,415
+9,397
+104% +$280K
IIIN icon
523
Insteel Industries
IIIN
$633M
$597K 0.03%
15,590
-4,248
-21% -$140K
EEFT icon
524
Euronet Worldwide
EEFT
$2.64B
$583K 0.03%
5,747
+204
+4% +$17.4K
ARLO icon
525
Arlo Technologies
ARLO
$1.59B
$580K 0.03%
60,928
+30,552
+101% +$279K

Similar funds

Hennion & Walsh Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Hennion & Walsh Asset Management held 890 positions worth $1.75B, up 12% from $1.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hennion & Walsh Asset Management's Q4 2023 filing shows 91 new, 326 increased, 388 reduced and 74 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 85,477 shares worth $6.01M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $6.66M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q4 2023 buy was iShares Core MSCI EAFE ETF: 85,477 shares worth $6.01M.
  • Hennion & Walsh Asset Management added most to iShares National Muni Bond ETF in Q4 2023, an estimated $3.48M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2023 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $6.66M.
  • Hennion & Walsh Asset Management fully exited Immunovant in Q4 2023, selling an estimated $5.49M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 16% of its $1.75B portfolio in Q4 2023.
  • Hennion & Walsh Asset Management opened 91 new positions and closed 74 in Q4 2023.
  • Hennion & Walsh Asset Management's portfolio value rose 12% quarter-over-quarter to $1.75B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.